Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders

By sjmartinez • January 24, 2023

Lazarus HM, Pitts K, Wang T, Lee E, Buchbinder E, Dougan M, Armstrong DG, Paine R 3rd, Ragsdale CE, Boyd T, Rock EP, Gale RP. Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders. Front Immunol. 2023 Jan 5;13:1069444. doi: 10.3389/fimmu.2022.1069444. PMID: 36685591; PMCID: PMC9850113.

Tags: autoimmune pulmonary alveolar proteinosis (aPAP), covid-19, granulocyte-macrophage colony-stimulating factor, immune checkpoint inhibitors (ICI), Immunomodulation, mononuclear phagocyte, Publications, Pulmonary, Critical Care & Sleep Medicine, sargramostim, wound healing

Earlier initiation of tenofovir in pregnancy with infant hepatitis B vaccination obviates the need for hepatitis B immune globulin

Pak K, Saab S. Earlier initiation of tenofovir in pregnancy with infant hepatitis B vaccination obviates the need for hepatitis B immune globulin. Transl Gastroenterol[...]

Intravitreal vascular endothelial growth factor inhibitor systemic and renal toxicity registry

Nguyen MD, Fekrat R, Gee C, Demirci AN, Kharabaf S, Le D, Tadros M, Nguyen VQ, Patel S, Truong T, Ahdoot R, Kurtz IB, Kerr[...]

Insurance companies’ lack of LGBTQ+ affirmation: discrimination, distrust, and dissatisfaction among LGBTQ+ people

Nowaskie DZ, Blackwood D, Garcia F, Flautero JD. Insurance companies' lack of LGBTQ+ affirmation: discrimination, distrust, and dissatisfaction among LGBTQ+ people. Front Sociol. 2025 Jul[...]